Dermatrix (CEO Kyung-hoon Kim), a skin digital healthcare solutions startup, announced on the 3rd that it had secured seed investment from deep-tech accelerator Bluepoint Partners. The investment amount and company value were not disclosed.
Dermatrix is a startup founded in 2025 by CEO Kim Kyung-hoon, a graduate of the dermatology department at Seoul Asan Medical Center. It is developing a solution that digitally connects the entire process from skin AI analysis to hospital data management and daily skin care for patients.
The company streamlines the entire process, from patient clinical photography and data management to clinical utilization and patient sharing, through its smart data management and automation solution for dermatology hospitals. It also automates the previously manual data organization and labeling process. Its stability and effectiveness have been proven over three years of operation at facilities like Seoul Asan Medical Center.
In addition, the company has advanced its specialized core technologies for skin treatment, including ▲AI classification of clinical skin photos ▲AI standardization of facial photos ▲AI detection of skin lesions. Dermatrix received recognition for its technological prowess and potential by winning the Grand Prize (Minister of Science and ICT Award) at the 2025 "Challenge! K-Startup" King of Kings Preliminary Startup League.
Following its hospital solution, the company is preparing to launch a mobile service that allows patients to record and manage their skin conditions in their daily lives. The goal is to connect hospital and patient data to provide personalized skin care and treatment experiences.
Bluepoint Partners Senior Analyst Kim Min-seon explained the investment background, saying, “We highly valued the company’s understanding of the medical field and its proven execution capabilities through its introduction to Seoul Asan Medical Center, and we believe it has the potential to grow into a global skin data platform.”
CEO Kim Kyung-hoon stated, “Our goal is to eliminate blind spots in skin health by connecting the clinical setting with daily life through data flow,” and added, “Through this investment, we will expand our R&D and service scope and strengthen the personalized skin care environment for patients.”
You must be logged in to post a comment.